Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;2(1):2-7.
doi: 10.4103/0975-7406.62694.

Patent protection strategies

Himanshu Gupta  1 , Suresh Kumar, Saroj Kumar Roy, R S Gaud
Affiliations

Patent protection strategies

Himanshu Gupta et al. J Pharm Bioallied Sci. 2010 Jan.

Abstract

It is widely recognized that the pharmaceutical industry faces serious financial challenges. Large numbers of blockbuster drugs are losing patent protection and going generic. The pipeline of new drugs is too sparse to fill the gap and generate a platform for future growth. Moreover, many of the new products are biologics with much narrower target patient populations and comparatively higher prices relative to traditional pharmaceuticals. So now the time has come for pharmaceutical scientists to have a better understanding of patent fundamentals. This need is illustrated by analyses of key scientific and legal issues that arose during recent patent infringement cases involving Prozac, Prilosec, and Buspar. Facing this scenario, the pharmaceutical industry has moved to accelerate drug development process and to adopt at the same time different strategies to extend the life time of the patent monopoly to provide the economic incentives and utilizing it for drug discovery and development. This review covers the need of patent protection and various strategies to extend the patent.

Keywords: Expiration; patent; pharmaceutical; racemate; strategies.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
U.S. patent application process[15]
See this image and copyright information in PMC

References

    1. Gersten DM. The quest for market exclusivity in biotechnology: Navigating the patent minefield. NeuroRx. 2005;2:572–8. - PMC - PubMed
    1. Grubb PW. 2nd ed. London, UK: Oxford University Press; 1999. Patents for Chemicals, Pharmaceuticals and Biotechnology. In fundamentals of global law, practice and strategy.
    1. Mackenzie M, Keating P, Cambrosio A. Patents and free scientific information in biotechnology: Making monoclonal antibodies proprietary. Sci Tech Hum Values. 1990;15:65–83.
    1. A Convergence of Science and Law. National Academy Press. [last cited in 2010 Jan 5]. Available from: http://www.nap.edu .
    1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Health Econ. 2003;22:151–85. - PubMed